Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Sci Rep ; 9(1): 14496, 2019 10 10.
Artigo em Inglês | MEDLINE | ID: mdl-31601899

RESUMO

The prevalence of osteopenia/osteoporosis has not been sufficiently studied in people with bronchiectasis not due to cystic fibrosis (BC), nor has its relationship with other variables (clinical, body composition and bone turnover and inflammation markers) been sufficiently studied. Our aim was to determine the prevalence of osteopenia and osteoporosis and related factors in patients with BC. We did a cross-sectional study in people with BC in a clinically stable state. Spirometric parameters, annual exacerbations and analysis with bone turnover markers (BTM) and inflammation markers were evaluated. Densitometry (DXA) was performed for body composition, bone mineral density (BMD) and handgrip strength. 123 patients were studied (65% women, mean age 49.6 ± 18.8, Body Mass Index (BMI) 24.8 ± 4.7 kg/m2). 62.8% and 62.5% of men and women, respectively, had normal bone mineral density, 30.2% and 22.2% osteopenia and 7% and 15% osteoporosis. 52 patients (56.2%) had low fat-free mass: 68.9% women and 28.6% men. Patients with decreased bone mass had significantly lower muscle strength, maximum expiratory volume in the first second (FEV1%), vitamin D, higher levels of C-terminal telopeptide of type 1 collagen (CTX) and total osteocalcin and underarboxylated osteocalcin (ucOC). We observed significant and negative correlations between BMD and the number of serious exacerbations per year CTX and undercarboxylated osteocalcin. We observed significant positive correlations between BMD, fat free mass index (FFMI) and handgrip dynamometry. The study suggest that the prevalence of osteoporosis was high in relation to the demographic characteristics. Respiratory parameters, body composition, muscle strength and bone remodeling markers were associated with a lower bone mineral density.


Assuntos
Biomarcadores/metabolismo , Doenças Ósseas Metabólicas/epidemiologia , Bronquiectasia/epidemiologia , Osteoporose/epidemiologia , Adulto , Idoso , Composição Corporal/fisiologia , Doenças Ósseas Metabólicas/complicações , Doenças Ósseas Metabólicas/metabolismo , Doenças Ósseas Metabólicas/fisiopatologia , Remodelação Óssea/genética , Bronquiectasia/complicações , Bronquiectasia/metabolismo , Bronquiectasia/fisiopatologia , Feminino , Força da Mão/fisiologia , Humanos , Masculino , Pessoa de Meia-Idade , Força Muscular/genética , Força Muscular/fisiologia , Osteoporose/complicações , Osteoporose/metabolismo , Osteoporose/fisiopatologia
2.
Nutr. hosp ; 39(2): 376-382, mar.- abr. 2022. graf, tab
Artigo em Inglês | IBECS (Espanha) | ID: ibc-209706

RESUMO

Introduction: few studies have evaluated body composition (BC) through different techniques, and the degree of agreement between them in adults with cystic fibrosis (CF). Objectives: to describe BC using techniques to assess nutritional status and to test their concordance in CF. Methods: a cross-sectional study in CF patients in a clinically stable situation. Nutritional assessment was performed using skinfold measurement (SM) and densitometry (DXA). Fat-free mass index (FFMI) was also determined. The diagnosis of malnutrition was established if body mass index (BMI) < 18.5 kg/m2. Fat-free mass (FFM) malnutrition was diagnosed when FFMI was < 17 kg/m2 in males and < 15 kg/m2 in females (FFMI: fat-free mass in kg/height in m2). Results: forty-one patients were studied (twenty-two females, 53.7 %); median age was 29.8 (interquartile range, 20.9-33.7); BMI was 21.6 (19.8-23.0). Only four (9.8 %) patients had a BMI < 18.5. By DXA, FFM (kg) results were: median, 52.8 (47.8-56.9) with FFMI of 17.9 (16.7-19.3) in males and 36.7 (33.1-38.9) in females, FFMI of 14.7 (14.2-15.8). Twenty (48.6 %) patients presented FFM malnutrition, with 16.7 % of males and 59.1 % of females being affected. By SM, the FFMI was 18.7 (17.2-20.0) in males and 14.9 (14.2-15.8) in females; moreover, sixteen (39.1 %) patients presented malnutrition of FFM, with 20.8 % of males and 61.8 % of females being affected. For FFM (kg), high concordance was obtained between SM and DXA (intraclass correlation coefficient of 0.950); likewise when they were compared by applying the ESPEN criteria for FFM malnutrition. However, when the techniques were compared to classify malnutrition according to FFMI, the kappa coefficient was only moderate (k = 0.440). The mean difference between FFM by DXA and SM was +1.44 ± 0.62 kg in favor of SM, with greater dispersion as FFM increased. Conclusions: the prevalence of FFM malnutrition is high in adult CF patients, despite a normal BMI, especially in females (AU)


Introducción: pocos estudios han evaluado la composición corporal (BC) mediante diferentes técnicas y el grado de concordancia entre ellas en adultos con fibrosis quística (FQ). Objetivos: describir la BC mediante técnicas de evaluación Nutricional y comprobar su concordancia en la FQ. Métodos: estudio transversal de adultos con FQ en situación de estabilidad clínica. La evaluación Nutricional se realizó mediante medición de pliegues cutáneos (SM) y densitometría (DXA). También se determinó el índice de masa libre de grasa (FFMI). El diagnóstico de desnutrición se estableció si el índice de masa corporal (IMC) era < 18,5 kg/m2. Se diagnosticó desnutrición por masa libre de grasa (FFM) cuando el FFMI era < 17 kg/m2 en los hombres y < 15 kg/m2 en las mujeres (FFMI: masa libre de grasa en kg/estatura en m2). Resultados: se estudiaron cuarenta y un pacientes (veintidós mujeres (53,7 %), con una edad media de 29,8 años (rango intercuartílico, 20,9-33,7) y un IMC de 21,6 (19,8-23,0). Solo cuatro (9,8 %) pacientes tenían un IMC < 18,5. Mediante DXA, los resultados de FFM (kg) fueron (mediana y RIC): 52,8 (47,8-56,9) con FFMI de 17,9 (16,7-19,3) en los varones y 36,7 (33,1-38,9) en las mujeres con FFMI de 14,7 (14,2-15,8). Veinte (48,6 %) pacientes presentaban desnutrición del FFM, con el 16,7 % de varones y el 59,1 % de mujeres afectados. Mediante el SM, el FFMI fue de 18,7 (17,2-20,0) en los varones y de 14,9 (14,2-15,8) en las mujeres; además, dieciséis (39,1 %) pacientes presentaban malnutrición del FFMI, con el 20,8 % de varones y el 61,8 % de mujeres afectados. En el caso de la FFM (kg), se obtuvo una alta concordancia entre el SM y la DXA (coeficiente de correlación intraclase de 0,950); igualmente cuando se compararon las técnicas aplicando los criterios ESPEN para la desnutrición de la FFM. Sin embargo, cuando se compararon las técnicas para clasificar la malnutrición según el FFMI, el coeficiente kappa fue solo moderado (coeficiente kappa = 0,440) (AU)


Assuntos
Humanos , Masculino , Feminino , Adulto Jovem , Adulto , Fibrose Cística/complicações , Desnutrição/diagnóstico , Desnutrição/etiologia , Estudos Transversais , Absorciometria de Fóton , Tecido Adiposo/diagnóstico por imagem , Composição Corporal , Índice de Massa Corporal , Impedância Elétrica , Avaliação Nutricional
3.
J Submicrosc Cytol Pathol ; 34(3): 315-21, 2002 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12408365

RESUMO

In order to evaluate the heart and liver responses after adriamycin (ADR) toxic aggression, with and without exogenous L-carnitine (CAR) protection, female Sprague-Dawley rats, body weight 40-60 g, were randomized into four groups: CON, ADR, CAR and CAR-ADR. ADR was injected i.v. at a dose of 15-18 mg/kg body wt (0.1 ml). CAR was administered i.v. at a dose of 20 mg (0.1 ml) before each subdose of ADR, and then orally at 180 mg/kg body wt daily for 12 weeks. Long-term cardiac and hepatic subcellular damage were determined by transmission electron microscopic analysis of ultrathin sections. The ADR-induced long-term cardiac subcellular pathology included loss, disruption and disassembly of myofibrils, and mitochondrial swelling and condensation. On the other hand, the ADR-induced subcellular hepatic alterations consisted of polymorphic mitochondria, cytoplasmic vacuolization and accumulation of lipid droplets. Apparently, cardiac tissue was more affected by ADR toxic aggression than hepatic tissue. However, these alterations were of less severity in protected groups, in both heart and liver, suggesting CAR as a possible hepatoprotector agent against ADR toxicity. Because of the liver-L-carnitine-heart relationship, studying ADR-hepatotoxicity could be helpful in the further understanding of severe ADR-cardiotoxicity.


Assuntos
Antineoplásicos/toxicidade , Carnitina/farmacologia , Doxorrubicina/toxicidade , Coração/efeitos dos fármacos , Fígado/efeitos dos fármacos , Administração Oral , Animais , Antineoplásicos/administração & dosagem , Cardiomiopatias/induzido quimicamente , Cardiomiopatias/patologia , Cardiomiopatias/prevenção & controle , Carnitina/administração & dosagem , Doença Hepática Induzida por Substâncias e Drogas , Doxorrubicina/administração & dosagem , Quimioterapia Combinada , Feminino , Injeções Intravenosas , Metabolismo dos Lipídeos , Fígado/metabolismo , Fígado/patologia , Hepatopatias/patologia , Hepatopatias/prevenção & controle , Dilatação Mitocondrial/efeitos dos fármacos , Miocárdio/metabolismo , Miocárdio/patologia , Miofibrilas/efeitos dos fármacos , Miofibrilas/ultraestrutura , Substâncias Protetoras/farmacologia , Ratos , Ratos Sprague-Dawley , Vacúolos/efeitos dos fármacos , Vacúolos/ultraestrutura
4.
Invest Clin ; 38(4): 219-26, 1997 Dec.
Artigo em Espanhol | MEDLINE | ID: mdl-9527389

RESUMO

Werner in 1915, described a patient is characterized by a tibial bilateral aplasia or hypoplasia, polydactyly and absent thumbs. Autosomal dominant inheritance is demonstrated, with variable expressivity. The objective of this work is to describe a child with clinic and radiologic signs of Tibial Hypoplasia with Polydactyly. The genealogic study allowed us to suppose that the gene has a variable expressivity, since in the maternal branch, malformations such as syndactyly of hands, proximal implantation of thumbs and tibiae vara, have been found. The clinic, radiologic, and genetic aspects are discussed.


Assuntos
Anormalidades Múltiplas/genética , Polidactilia/genética , Polegar/anormalidades , Tíbia/anormalidades , Feminino , Deformidades Congênitas do Pé/genética , Luxação Congênita de Quadril/genética , Humanos , Recém-Nascido , Linhagem , Estenose Pilórica/congênito , Sindactilia/genética , Venezuela
5.
Eur J Endocrinol ; 165(3): 435-9, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21715417

RESUMO

OBJECTIVE: Changes in eating habits may be influential in the ever-increasing rate of childhood obesity. Our aim was to determine whether those children who consume olive oil have a lower risk of weight gain compared with children who consume other oils. DESIGN AND METHODS: The study included 18 girls and 74 boys, all aged 13-166 months. A survey was completed for each subject about eating habits and physical activity. A sample of subcutaneous adipose tissue was also obtained for cellular study. Data were recorded on the mean size of the adipocytes, the number of preadipocytes, and the concentration of particular fatty acids. The weight and height of the children were measured 13 months later. RESULTS: The likelihood that after 1 year the children would have increased their body mass index (BMI) Z-score above the initial score was less in the children who consumed only olive oil (odds ratio (OR)=0.22; 95% confidence interval (CI): 0.08-0.63; P=0.005). These results remained after adjusting for age, physical activity and BMI (OR=0.19; 95% CI: 0.06-0.61; P=0.005) and after adjusting for age, physical activity and adipocyte volume (OR=0.15; 95% CI: 0.04-0.52; P=0.003). CONCLUSIONS: Diets with mono unsaturated fatty acid (MUFA)-rich olive oil could reduce the risk of obesity in childhood.


Assuntos
Gorduras na Dieta , Obesidade/prevenção & controle , Óleos de Plantas/administração & dosagem , Tecido Adiposo/citologia , Adolescente , Índice de Massa Corporal , Peso Corporal , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Azeite de Oliva , Aumento de Peso
6.
Arch. venez. farmacol. ter ; 21(2): 201-204, 2002. ilus, tab, graf
Artigo em Espanhol | LILACS | ID: lil-355117

RESUMO

La cepa Sprague Dawley representa un modelo animal usado para evaluar el potencial terapéutico y tóxico de drogas y permite la elaboración de diseños experimentales para estudiar órgano toxicidad, síendo el hígado uno de los órganos mas estudiados. Una manera indirecta de evaluar la condición del indiviuo y el órgano afectado, es la determinación sérica de metabolitos específicos, lo cual exige el establecimiento de rangos de referencia de marcadores universales para la detección de daño orgánico. Aplicando un diseño no experimental, se determinaron los valores séricos normales de y-GT, TGP, Bt, Bd y Tg, en ratas hembras Sprague Dawley, de 150-250 g de peso corporal (p.c), empleando métodos optimizados para humanos. Se extrajeron 3 cc de sangre, mediante punción directa de la arteria aorta a 40 ratas, posterior a su sacrificio con vapores de cloroformo. Las muestras fueron centrifugadas 15 min. separando el suero para la determinación de los parámetros químicos establecidos, con el uso de estuches comerciales de técnica manual. Se calculó el promedio y la desviación estándar de los valores obtenidos arrojando los siguientes rangos de valores de referencia: y-GT (16.0 UI/Lñ7.2), TGP (32.5 UI/Lñ9.5), Bt (0.36 mg/dlñ0.18), Bd (0,08 mg/dlñ0.04) y Tg (88 mg/dlñ30) y un promedio de p.c de 203 gñ21. Las similitudes y diferencias entre los valores obtenidos y los reportados por otros investigadores, sugieren que cambios ambientales, alimenticios y de cautiverio pudieran modificar los niveles de metabolitos séricos en estos animales experimentales


Assuntos
Animais , Biomarcadores , Ratos Sprague-Dawley , Biologia , Venezuela
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa